Repligen Corp

RGEN: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|L#LOCK|<b<<!LOCK|W<>^#zK

Repligen Earnings: Double-Digit Top-Line Growth Supports Recovery

Repligen reported year-on-year revenue growth of 10% and an adjusted operating margin of 13.8%, which is 4.9 percentage points better than the same period last year. The company refreshed its full-year guidance ranges, with slightly better revenue offset by slightly worse margins.

Sponsor Center